CIBC World Market Portfolio holdings
AUM
$45.2B
1-Year Return
22.83%
This Quarter Return
+0.09%
1 Year Return
+22.83%
3 Year Return
+49.01%
5 Year Return
+115.31%
10 Year Return
+208.89%
AUM
$43.8B
AUM Growth
+$369M
(+0.85%)
Cap. Flow
+$1.11B
Cap. Flow
% of AUM
2.54%
Top 10 Holdings %
Top 10 Hldgs %
34.92%
Holding
1,371
New
104
Increased
569
Reduced
526
Closed
102
Top Buys
| 1 |
Canadian Natural Resources
CNQ
|
$219M |
| 2 |
Novartis
NVS
|
$202M |
| 3 |
The Communication Services Select Sector SPDR Fund
XLC
|
$189M |
| 4 |
Suncor Energy
SU
|
$160M |
| 5 |
JPMorgan Chase
JPM
|
$146M |
Top Sells
| 1 |
Materials Select Sector SPDR Fund
XLB
|
$123M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$94.9M |
| 3 |
iShares Russell 2000 ETF
IWM
|
$89.9M |
| 4 |
SPDR Dow Jones Industrial Average ETF Trust
DIA
|
$82.4M |
| 5 |
Thomson Reuters
TRI
|
$82.3M |
Sector Composition
| 1 | Financials | 33.18% |
| 2 | Energy | 14.02% |
| 3 | Technology | 12.18% |
| 4 | Communication Services | 7.46% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Recursion Pharmaceuticals
RXRX
$2.02B
| $100K | ﹤0.01% |
18,985
-1,932
| -9% | -$10.2K |
|
|
SVM
1227
Silvercorp Metals
SVM
$1.08B
| $89.1K | ﹤0.01% |
23,100
+1,203
| +5% | +$4.64K |
|
1228
Tilray
TLRY
$1.3B
| $82.3K | ﹤0.01% |
125,237
+30,892
| +33% | +$20.3K |
|
1229
Under Armour Class C
UA
$2.16B
| $79.3K | ﹤0.01% |
13,320
-29,684
| -69% | -$177K |
|
1230
LifeMD
LFMD
$293M
| $78.9K | ﹤0.01% |
14,500
| – | – |
|
|
ADAM
1231
Adamas Trust, Inc. Common Stock
ADAM
$670M
| $77.9K | ﹤0.01% |
+12,000
| New | +$77.9K |
|
1232
NIO
NIO
$13.5B
| $75.2K | ﹤0.01% |
19,730
+3,649
| +23% | +$13.9K |
|
|
VERV
1233
DELISTED
Verve Therapeutics
VERV
| $73.3K | ﹤0.01% |
16,044
-1,682
| -9% | -$7.69K |
|
1234
Pacific Biosciences
PACB
$375M
| $68.6K | ﹤0.01% |
+58,100
| New | +$68.6K |
|
1235
Sunrun
RUN
$4.15B
| $67.6K | ﹤0.01% |
11,533
-845
| -7% | -$4.95K |
|
1236
Microvision
MVIS
$328M
| $58.3K | ﹤0.01% |
47,018
+26,700
| +131% | +$33.1K |
|
|
PHK
1237
PIMCO High Income Fund
PHK
$857M
| $57.4K | ﹤0.01% |
11,730
+730
| +7% | +$3.57K |
|
1238
Heron Therapeutics
HRTX
$199M
| $57K | ﹤0.01% |
+25,900
| New | +$57K |
|
1239
ChargePoint
CHPT
$234M
| $54.2K | ﹤0.01% |
4,477
+723
| +19% | +$8.75K |
|
1240
Nano X Imaging
NNOX
$236M
| $52.9K | ﹤0.01% |
+10,600
| New | +$52.9K |
|
1241
AbCellera Biologics
ABCL
$1.27B
| $52.6K | ﹤0.01% |
23,565
+6,700
| +40% | +$14.9K |
|
1242
Opko Health
OPK
$1.08B
| $49.7K | ﹤0.01% |
29,928
| – | – |
|
1243
Edesa Biotech
EDSA
$17.6M
| $48.8K | ﹤0.01% |
+19,999
| New | +$48.8K |
|
1244
Sana Biotechnology
SANA
$757M
| $47K | ﹤0.01% |
+28,000
| New | +$47K |
|
1245
Ocugen
OCGN
$322M
| $43.4K | ﹤0.01% |
61,500
+37,000
| +151% | +$26.1K |
|
|
GLDG
1246
GoldMining Inc
GLDG
$213M
| $42.5K | ﹤0.01% |
50,980
| – | – |
|
|
NMG
1247
Nouveau Monde Graphite
NMG
$291M
| $40.7K | ﹤0.01% |
27,359
-5,153
| -16% | -$7.67K |
|
1248
ImmunityBio
IBRX
$2.32B
| $38.2K | ﹤0.01% |
12,700
| – | – |
|
1249
Getty Images
GETY
$759M
| $38.1K | ﹤0.01% |
+22,000
| New | +$38.1K |
|
|
NFGC
1250
New Found Gold
NFGC
$440M
| $37.3K | ﹤0.01% |
31,050
-28,000
| -47% | -$33.7K |
|